ROY F CHEMALY to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications ROY F CHEMALY has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.334
-
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies. Blood. 2022 08 18; 140(7):673-684.
Score: 0.172
-
Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022). Transplant Cell Ther. 2022 12; 28(12):810-821.
Score: 0.043
-
American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation. Transplant Cell Ther. 2021 12; 27(12):957-967.
Score: 0.040
-
American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation. Transplant Cell Ther. 2021 09; 27(9):707-719.
Score: 0.040
-
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients. Biol Blood Marrow Transplant. 2020 11; 26(11):1983-1994.
Score: 0.037